Clinical trials
Phase 3 Carcinoma, Hepatocellular trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
| Completed | 4 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Bayer | 2 |
| Hoffmann-La Roche | 2 |
| Abbott | 1 |
| Bristol-Myers Squibb | 1 |
| Exelixis | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 10 |
| Liver Neoplasms | 6 |
| Neoplasms | 3 |
| Carcinoma | 2 |
| Adenocarcinoma | 1 |
| Digestive System Diseases | 1 |
| Digestive System Neoplasms | 1 |
| Liver Diseases | 1 |
| Neoplasms by Histologic Type | 1 |
| Neoplasms by Site | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.